Open AccessThe use of biological bronchoscopic lung volume reduction therapy in chronic obstructive pulmonary disease patients
Author(s) -
Mohamed A. Atta,
Ahmed M. Kassem,
Alaa E. Abdallah,
Abdelaziz Elnekidy
Publication year - 2017
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.1016/j.ejcdt.2016.10.013
Subject(s) - medicine , copd , lung volume reduction surgery , lung volumes , lung , pulmonary disease , bronchoscopy , reduction (mathematics) , obstructive lung disease , lung disease , lung volume reduction , surgery , geometry , mathematics
BackgroundLung volume reduction can be accomplished bronchoscopically, a procedure that represents a potential alternative to LVRS.Aim of the workEvaluation of the role of the effectiveness of biological bronchoscopic lung volume reduction (BBLVR) in COPD patients.Methods20 COPD patients were recruited for biological bronchoscopic lung volume reduction (BBLVR). All patients were subjected to dyspnea grade, PaO2, FEV1% of predicted, size of bullae before and 2weeks after BBLVR.ResultsThere was statistically significant improvement in dyspnea grade, PaO2, FEV1% of predicted, size of bullae before and 2weeks after BBLVR, with no detected complications.ConclusionBiological bronchoscopic lung volume reduction (BBLVR) is safe and effective in COPD patients